These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33622343)

  • 1. Sequential filtering for clinically relevant variants as a method for clinical interpretation of whole exome sequencing findings in glioma.
    Ülgen E; Can Ö; Bilguvar K; Akyerli Boylu C; Kılıçturgay Yüksel Ş; Erşen Danyeli A; Sezerman OU; Yakıcıer MC; Pamir MN; Özduman K
    BMC Med Genomics; 2021 Feb; 14(1):54. PubMed ID: 33622343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
    Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
    Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliable Analysis of Clinical Tumor-Only Whole-Exome Sequencing Data.
    Oh S; Geistlinger L; Ramos M; Morgan M; Waldron L; Riester M
    JCO Clin Cancer Inform; 2020 Apr; 4():321-335. PubMed ID: 32282230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series.
    Jacobs DI; Fukumura K; Bainbridge MN; Armstrong GN; Tsavachidis S; Gu X; Doddapaneni HV; Hu J; Jayaseelan JC; Muzny DM; Huse JT; Bondy ML
    Neuro Oncol; 2018 Nov; 20(12):1625-1633. PubMed ID: 30165405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR gene variants are associated with specific somatic aberrations in glioma.
    Wibom C; Ghasimi S; Van Loo P; Brännström T; Trygg J; Lau C; Henriksson R; Bergenheim T; Andersson U; Rydén P; Melin B
    PLoS One; 2012; 7(12):e47929. PubMed ID: 23236348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas.
    Shin H; Sa JK; Bae JS; Koo H; Jin S; Cho HJ; Choi SW; Kyoung JM; Kim JY; Seo YJ; Joung JG; Kim NKD; Son DS; Chung J; Lee T; Kong DS; Choi JW; Seol HJ; Lee JI; Suh YL; Park WY; Nam DH
    Cancer Res Treat; 2020 Jan; 52(1):41-50. PubMed ID: 31096737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.
    Ramarao-Milne P; Kondrashova O; Patch AM; Nones K; Koufariotis LT; Newell F; Addala V; Lakis V; Holmes O; Leonard C; Wood S; Xu Q; Mukhopadhyay P; Naeini MM; Steinfort D; Williamson JP; Bint M; Pahoff C; Nguyen PT; Twaddell S; Arnold D; Grainge C; Basirzadeh F; Fielding D; Dalley AJ; Chittoory H; Simpson PT; Aoude LG; Bonazzi VF; Patel K; Barbour AP; Fennell DA; Robinson BW; Creaney J; Hollway G; Pearson JV; Waddell N
    ESMO Open; 2022 Aug; 7(4):100540. PubMed ID: 35849877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and Immunotherapies.
    Cao J; Chen L; Li H; Chen H; Yao J; Mu S; Liu W; Zhang P; Cheng Y; Liu B; Hu Z; Chen D; Kang H; Hu J; Wang A; Wang W; Yao M; Chrin G; Wang X; Zhao W; Li L; Xu L; Guo W; Jia J; Chen J; Wang K; Li G; Shi W
    Oncologist; 2019 Dec; 24(12):e1294-e1302. PubMed ID: 31409745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor mutational burden is associated with poor outcomes in diffuse glioma.
    Wang L; Ge J; Lan Y; Shi Y; Luo Y; Tan Y; Liang M; Deng S; Zhang X; Wang W; Tan Y; Xu Y; Luo T
    BMC Cancer; 2020 Mar; 20(1):213. PubMed ID: 32164609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor mutational burden and driver mutations: Characterizing the genomic landscape of pediatric brain tumors.
    Patel RR; Ramkissoon SH; Ross J; Weintraub L
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28338. PubMed ID: 32386112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
    Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
    Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases.
    Na K; Kim HS; Shim HS; Chang JH; Kang SG; Kim SH
    J Neurooncol; 2019 May; 142(3):445-454. PubMed ID: 30710203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and clinical application of an integrative genomic approach to personalized cancer therapy.
    Uzilov AV; Ding W; Fink MY; Antipin Y; Brohl AS; Davis C; Lau CY; Pandya C; Shah H; Kasai Y; Powell J; Micchelli M; Castellanos R; Zhang Z; Linderman M; Kinoshita Y; Zweig M; Raustad K; Cheung K; Castillo D; Wooten M; Bourzgui I; Newman LC; Deikus G; Mathew B; Zhu J; Glicksberg BS; Moe AS; Liao J; Edelmann L; Dudley JT; Maki RG; Kasarskis A; Holcombe RF; Mahajan M; Hao K; Reva B; Longtine J; Starcevic D; Sebra R; Donovan MJ; Li S; Schadt EE; Chen R
    Genome Med; 2016 Jun; 8(1):62. PubMed ID: 27245685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma.
    Gorovets D; Kannan K; Shen R; Kastenhuber ER; Islamdoust N; Campos C; Pentsova E; Heguy A; Jhanwar SC; Mellinghoff IK; Chan TA; Huse JT
    Clin Cancer Res; 2012 May; 18(9):2490-501. PubMed ID: 22415316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A scalable solution for tumor mutational burden from formalin-fixed, paraffin-embedded samples using the Oncomine Tumor Mutation Load Assay.
    Chaudhary R; Quagliata L; Martin JP; Alborelli I; Cyanam D; Mittal V; Tom W; Au-Young J; Sadis S; Hyland F
    Transl Lung Cancer Res; 2018 Dec; 7(6):616-630. PubMed ID: 30505706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiling and comprehensive genome-wide analysis of somatic copy number alterations in gastric intramucosal neoplasias based on microsatellite status.
    Sugai T; Eizuka M; Arakawa N; Osakabe M; Habano W; Fujita Y; Yamamoto E; Yamano H; Endoh M; Matsumoto T; Suzuki H
    Gastric Cancer; 2018 Sep; 21(5):765-775. PubMed ID: 29468422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer.
    Kaur P; Campo D; Porras TB; Ring A; Lu J; Chairez Y; Su Y; Kang I; Lang JE
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ancestry and frequency of genetic variants in the general population are confounders in the characterization of germline variants linked to cancer.
    Bobyn A; Zarrei M; Zhu Y; Hoffman M; Brenner D; Resnick AC; Scherer SW; Gallo M
    BMC Med Genet; 2020 May; 21(1):92. PubMed ID: 32375678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Germline Variants rs61757955 and rs34988193 Are Predictive of Survival in Lower Grade Glioma Patients.
    Chatrath A; Kiran M; Kumar P; Ratan A; Dutta A
    Mol Cancer Res; 2019 May; 17(5):1075-1086. PubMed ID: 30651372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.